{
  "ptid_time": "099_S_2063_2012-10-15",
  "img_path": "/data/qiuhui/data/adni/images/099_S_2063/2012-10-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 41,471 mm³, 7.7% above the reference mean. With a Z-score of 0.18 (57.3th percentile), this represents normal volume ; hippocampal volume measures 8,751 mm³, 15.8% above the reference mean. With a Z-score of 1.54 (93.8th percentile), this represents moderate enlargement; whole brain volume measures 1,183,660 mm³, 9.7% above the reference mean. With a Z-score of 1.25 (89.5th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,368 mm³, 6.5% above the reference mean. With a Z-score of 0.44 (67.1th percentile), this represents normal volume ; fusiform gyrus volume measures 19,926 mm³, 5.8% above the reference mean. With a Z-score of 0.49 (68.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,101 mm³, 3.6% above the reference mean. With a Z-score of 0.32 (62.6th percentile), this represents normal volume . ",
  "text_data": "Age is 70.3 years. Gender is Male. Education: 16 years. MMSE: 30.0. MoCA: 20.0. Logical Memory: 19.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.40 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows no significant atrophy, with most regions (including the hippocampus and entorhinal cortex) at or above the reference mean. However, the MoCA score of 20 suggests cognitive impairment, while the MMSE of 30 is normal—this discrepancy raises suspicion of early cognitive decline, particularly given the elevated AV45 (amyloid positivity) and APOE4 carrier status.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting MMSE/MoCA scores but supportive biomarker evidence of amyloid pathology)",
  "timestamp": "2025-07-26T11:02:19.210950"
}